Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $253.00. The company’s shares closed last Friday at $248.04.
According to TipRanks.com, Harrison is a 5-star analyst with an average return of 7.4% and a 52.0% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Centessa Pharmaceuticals, BioMarin Pharmaceutical, and Vertex Pharmaceuticals.
Amgen has an analyst consensus of Hold, with a price target consensus of $250.57, implying a 1.3% upside from current levels. In a report issued on July 7, RBC Capital also maintained a Hold rating on the stock with a $224.00 price target.
See the top stocks recommended by analysts >>
Based on Amgen’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $6.24 billion and net profit of $1.48 billion. In comparison, last year the company earned revenue of $5.9 billion and had a net profit of $1.65 billion.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1980, California-based Amgen, Inc. is one of the world’s leading biotechnology companies, which is engaged in the discovery, development, manufacture and marketing of human therapeutics. It primarily focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas.
Read More on AMGN:
- Morgan Stanley Sticks to Their Sell Rating for Abiomed (ABMD)
- Analysts’ Opinions Are Mixed on These Technology Stocks: Seagate Tech (STX), Maxar Technologies (MAXR) and Certara (CERT)
- Analysts Offer Insights on Financial Companies: First Republic Bank (FRC) and Synchrony Financial (SYF)
- Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), ACADIA Pharmaceuticals (ACAD) and Alnylam Pharma (ALNY)
- Analysts Offer Insights on Industrial Goods Companies: 3M (MMM) and Canadian National Railway (CNI)
